Reduced serum LEFTY2 and disease-dependent biomarker associations in Alzheimer’s disease: an exploratory study
Reliable blood-based biomarkers are increasingly needed for the detection and monitoring of Alzheimer’s disease (AD). Left–right determination factor 2 (LEFTY2) is a secreted protein of the transforming growth factor-β (TGF-β) superfamily. Evidence from AD-related neuronal models suggests that LEFTY2 promotes neuronal...